Yonhap Infomax NewsThe JP Morgan Healthcare Conference spotlighted AI-biotech convergence, fierce obesity drug competition, South Korean biosimilar firms' new drug push, and Hanmi Pharmaceutical's share plunge, underscoring global shifts in pharma innovation and market dynamics.
#YonhapInfomax #JPmorganHealthcare #ArtificialIntelligence #ObesityDrugs #HanmiPharmaceutical #BiosimilarDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100312
#YonhapInfomax #JPmorganHealthcare #ArtificialIntelligence #ObesityDrugs #HanmiPharmaceutical #BiosimilarDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100312
JP Morgan Healthcare Conference Highlights—AI Integration and Intensifying New Drug Race
The JP Morgan Healthcare Conference spotlighted AI-biotech convergence, fierce obesity drug competition, South Korean biosimilar firms' new drug push, and Hanmi Pharmaceutical's share plunge, underscoring global shifts in pharma innovation and market dynamics.